Fat embolism syndrome: Difference between revisions
Jump to navigation
Jump to search
Aditya Ganti (talk | contribs) No edit summary |
|||
| (6 intermediate revisions by 3 users not shown) | |||
| Line 13: | Line 13: | ||
MeshNumber = C14.907.355.350.454 | | MeshNumber = C14.907.355.350.454 | | ||
}} | }} | ||
{{Fat embolism syndrome}} | {{Fat embolism syndrome}} | ||
'''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | '''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | ||
{{CMG}} | {{CMG}} {{AE}} {{FT}} {{ADG}} | ||
{{SK}} FES | {{SK}} FES; fat emobolism | ||
==[[Fat embolism syndrome overview|Overview]]== | ==[[Fat embolism syndrome overview|Overview]]== | ||
==[[Fat embolism syndrome historical perspective|Historical Perspective]]== | ==[[Fat embolism syndrome historical perspective|Historical Perspective]]== | ||
==[[Fat embolism syndrome classification|Classification]]== | |||
==[[Fat embolism syndrome pathophysiology|Pathophysiology]]== | ==[[Fat embolism syndrome pathophysiology|Pathophysiology]]== | ||
| Line 29: | Line 31: | ||
==[[Fat embolism syndrome causes|Causes]]== | ==[[Fat embolism syndrome causes|Causes]]== | ||
==[[Fat embolism syndrome differential diagnosis|Differentiating Fat | ==[[Fat embolism syndrome differential diagnosis|Differentiating Fat Embolism Syndrome from other Diseases]]== | ||
==[[Fat embolism syndrome epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Fat embolism syndrome epidemiology and demographics|Epidemiology and Demographics]]== | ||
| Line 41: | Line 43: | ||
==Treatment== | ==Treatment== | ||
[[Fat embolism syndrome medical therapy|Medical Therapy]] | [[Fat embolism syndrome surgery|Surgery]] | [[Fat embolism syndrome primary prevention|Primary Prevention]] | [[Fat embolism syndrome cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Fat embolism syndrome future or investigational therapies|Future or Investigational Therapies]] | [[Fat embolism syndrome medical therapy|Medical Therapy]] | [[Fat embolism syndrome surgery|Surgery]] | [[Fat embolism syndrome primary prevention|Primary Prevention]] | [[Fat embolism syndrome secondary prevention|Secondary Prevention]] | [[Fat embolism syndrome cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Fat embolism syndrome future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
[[Fat embolism syndrome case study one|Case #1]] | [[Fat embolism syndrome case study one|Case #1]] | ||
| Line 59: | Line 60: | ||
[[Category:Pulmonology]] | [[Category:Pulmonology]] | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
[[Category:Orthopedics]] | |||
Latest revision as of 06:06, 6 July 2020
| Fat embolism syndrome | ||
| ICD-10 | O88.8, T79.1 | |
|---|---|---|
| ICD-9 | 673.8 | |
| DiseasesDB | 4766 | |
| MeSH | C14.907.355.350.454 | |
|
Fat embolism syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fat embolism syndrome On the Web |
|
American Roentgen Ray Society Images of Fat embolism syndrome |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Feham Tariq, MD [2] Aditya Ganti M.B.B.S. [3]
Synonyms and keywords: FES; fat emobolism
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Fat Embolism Syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies